These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2841513

  • 1. [Pathogenesis of atherosclerosis and blood platelets: problems of platelet activation in arteriosclerosis--with special reference to platelet membrane receptors].
    Satoh Y, Tanaka Y, Satoh H.
    Nihon Rinsho; 1988 Mar; 46(3):582-9. PubMed ID: 2841513
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL, Harker LA, Andersen NH, Wilson CH.
    Adv Prostaglandin Thromboxane Res; 1980 Mar; 6():389-93. PubMed ID: 6247888
    [No Abstract] [Full Text] [Related]

  • 3. [Receptors on the platelet membrane].
    Watanabe K, Ando Y.
    Rinsho Byori; 1985 Jul; 33(7):726-33. PubMed ID: 2999470
    [No Abstract] [Full Text] [Related]

  • 4. [Pathogenesis of atherosclerosis and blood platelets: platelet-derived growth factor and atherosclerosis].
    Kawahara Y, Kariya K, Fukuzaki H.
    Nihon Rinsho; 1988 Mar; 46(3):565-73. PubMed ID: 3404683
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 6. Interaction of the protein C activation peptide with platelets.
    Martínez-Cruz R, Canseco Mdel S, Lopez-Martínez J, Cruz PA, Pérez-Campos E, Cruz MM, Alva FC, Majluf-Cruz A, Zenteno E, Ruiz-Argüelles A.
    Prep Biochem Biotechnol; 2007 May; 37(2):139-47. PubMed ID: 17454824
    [Abstract] [Full Text] [Related]

  • 7. Platelet membrane components and receptors.
    Niewiarowski S.
    Haematologia (Budap); 1987 May; 20(1):3-14. PubMed ID: 3036672
    [Abstract] [Full Text] [Related]

  • 8. The activation of platelets by thrombin: a model for activation by high and moderate affinity receptor pathways.
    Jamieson GA.
    Prog Clin Biol Res; 1988 May; 283():137-58. PubMed ID: 2850570
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
    Cooper B, Ahern D.
    J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of GPIV as a platelet receptor for collagen adhesion.
    Tandon NN, Jamieson GA.
    Prog Clin Biol Res; 1988 Aug; 283():315-8. PubMed ID: 2850574
    [No Abstract] [Full Text] [Related]

  • 12. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE, Burch RM, Saussy DL, Kochel PJ, Halushka PV.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [Abstract] [Full Text] [Related]

  • 13. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR.
    Adv Prostaglandin Thromboxane Res; 1980 Dec; 6():417-25. PubMed ID: 6247892
    [No Abstract] [Full Text] [Related]

  • 14. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S, Oliva D, Bernini F, Fumagalli R.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Dec; 17():593-9. PubMed ID: 6328938
    [No Abstract] [Full Text] [Related]

  • 15. [Defects in the prostaglandin system. II. Familial platelet-prostacyclin receptor defect (Wien-Hietzing defect)--pathogenetic significance for (early) development of atherosclerosis?].
    Kaliman J, Sinzinger H, Staudacher M, Mannheimer E.
    Wien Klin Wochenschr; 1985 Mar 29; 97(7):323-6. PubMed ID: 2986363
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Young male smokers have altered platelets and endothelium that precedes atherosclerosis.
    Casey RG, Joyce M, Roche-Nagle G, Cox D, Bouchier-Hayes DJ.
    J Surg Res; 2004 Feb 29; 116(2):227-33. PubMed ID: 15013360
    [Abstract] [Full Text] [Related]

  • 18. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ, Shattil SJ, Ferry N, Rozansky D, Insel PA.
    Mol Pharmacol; 1986 Jan 29; 29(1):1-6. PubMed ID: 2418346
    [Abstract] [Full Text] [Related]

  • 19. Normal mechanisms of platelet function.
    Vermylen J, Badenhorst PN, Deckmyn H, Arnout J.
    Clin Haematol; 1983 Feb 29; 12(1):107-51. PubMed ID: 6301715
    [No Abstract] [Full Text] [Related]

  • 20. Up-regulation of prostaglandin D2 receptors by agonist binding to beta-adrenoceptors in rabbit platelets.
    Ichikawa A, Mizuno Y, Hanasaki K, Yoshimura S, Tomita K.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Feb 29; 15():671-2. PubMed ID: 3004152
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.